HR 020602
Alternative Names: HR020602Latest Information Update: 10 May 2021
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class General anaesthetics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Anaesthesia
Most Recent Events
- 10 May 2021 Preclinical trials in Anaesthesia in China (IV) before May 2021
- 10 May 2021 Jiangsu HengRui Medicine plans a phase II trial in Anesthesia (In adolescents, In children) (IV) in May 2021 (NCT04867343)